CHRONIC MYELOID LEUKEMIA
Clinical trials for CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell boost after transplant shows promise against tough blood cancers
Disease control CompletedThis study tested whether adding ready-made natural killer (NK) cells from a donor to a standard stem cell transplant could safely reduce the chance of cancer coming back in people with high-risk myeloid cancers like acute myeloid leukemia. Twenty-four patients aged 18 to 70 took…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:32 UTC
-
Can CML patients ditch daily pills? new study tests Drug-Free remission
Disease control CompletedThis study looked at whether people with chronic myeloid leukemia (CML) who have been on the drug nilotinib for at least 3 years can safely stop treatment and remain cancer-free. It also tested if adding another drug, asciminib, could help those who needed to restart medication t…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
New combo therapy shows promise in CML battle
Disease control CompletedThis study tested whether adding a drug called pegylated interferon to the standard treatment nilotinib helps people with newly diagnosed chronic myeloid leukemia (CML) achieve a deeper molecular response. 200 adults under 65 took part. The goal was to see if the combination lead…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
Leukemia drug holiday: many patients stay in remission after stopping nilotinib
Disease control CompletedThis study looked at whether people with chronic myeloid leukemia (CML) could safely stop taking the drug nilotinib (Tasigna) if their cancer was already deeply suppressed. Participants had been on nilotinib for at least 2 years and had very low levels of leukemia cells. The goal…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Healthy men help track leukemia Drug's path
Knowledge-focused CompletedThis study looked at how a drug called TGRX-678, used for chronic myeloid leukemia, is absorbed, broken down, and removed from the body. Six healthy men took a single radioactive dose so researchers could measure the drug in their blood, urine, and stool. The goal was not to trea…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC